Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Biological half-life | 2–4 hours |
Identifiers | |
|
|
Synonyms | U-10997; CDB-904; 7α,17α-dimethyl-19-nortestosterone; 7α,17α-Dimethylestr-4-en-17β-ol-3-one |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.020.951 |
Chemical and physical data | |
Formula | C20H30O2 |
Molar mass | 302.4558 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) |
Mibolerone (INN, USAN, BAN) (brand names Cheque Drops, Matenon; developmental code name U-10997), also known as 7α,17α-dimethyl-19-nortestosterone (DMNT), is a potent, orally active anabolic-androgenic steroid (AAS) and 17α-alkylated derivative of nandrolone (19-nortestosterone) that was marketed by Upjohn for use as a veterinary drug. It was indicated as an oral treatment for prevention of estrus (heat) in adult female dogs. Mibolerone is the 17α-methyl derivative of trestolone (7α-methyl-19-nortestosterone; MENT). It has both higher affinity and greater selectivity for the androgen receptor (AR) than does the related potent AAS metribolone (17α-methyl-19-nor-δ9,11-testosterone), although potent and significant progestogenic activity remains present. However, another study found that mibolerone and metribolone had similar affinity for the progesterone receptor (PR) but that mibolerone only had around half the affinity of metribolone for the AR.
Nandrolone (1) appears to be used to make mibolerone. For comparison, also see bolasterone and calusterone. The first step involves extending the conjugation of the enone function by an additional double bond. Chloranil (tetrachloroquinone) is the forerunner of dichlorodicyanoquinone (DDQ), a reagent used extensively for introducing additional unsaturation in the progestin and corticoid series.